ClinicalTrials.gg
Status unknownNCT02751476Updated Jan 31, 2017

Effectiveness of Safe Drinking Water in Treatment of Severe Acute Malnutrition (Pakistan)

An interventional study of Point of Use (PoU) water treatment flocculent disinfectant. and Point of Use (PoU) water treatment chlorine disinfectant in Marasmus, sponsored by Action Contre la Faim. Status unknown. Open to participants aged 6 Months to 59 Months. Per ClinicalTrials.gov, last updated 2017-01-31.

Sponsored by Action Contre la Faim · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2017), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
820
Allocation
Randomized
Ages
6 Months to 59 Months
Sex
All
01

Study summary

This study builds evidence on the importance of using safe drinking water during the nutritional treatment of children affected by Severe Acute Malnutrition (SAM). The following hypotheses will be tested: 1.The addition of safe drinking water to SAM treatment will reduce exposure to pathogens that cause diarrhoeal disease, thereby reducing diarrhoea incidence among enrolled children. 2.Reductions in pathogen exposure and diarrhoeal disease will result in shorter recovery pe-riods for children with SAM. The study will evaluate the effectiveness of safe drinking water in reducing SAM treatment cost and duration and will provide recommendations for improving SAM treatment protocols.

Read the detailed description

A four group randomized control trial (RCT) will be used to evaluate the effectiveness of safe drinking water in SAM treatment protocols. Intervention groups will include: 1) standard SAM treatment (control group); 2) standard SAM treatment + flocculent-disinfectant water treatment (P\&G Purifier of Water); 3) standard SAM treatment + chlorine disinfectant ("Aquatabs", a locally available mass market product); and 4) standard SAM treatment + ceramic water filter (locally available mass market product). All intervention groups will receive the standard SAM nutrition treatment and hygiene education. The control group will receive standard Community Managed Acute Malnutrition (CMAM) treatment only and households will use existing water treatment methods to represent the conventional CMAM program and to enable comparison with the other study arms (with improved water provision methods). A RCT was identified because it is a rigorous gold standard methodology design that is feasible given the context, and appropriate for determining whether or not safe drinking water is effective in CMAM programs. Site level randomization will be used and is preferable to individual randomization from a management perspective and because it increases likelihood of fidelity to the planned intervention. Limitations of the proposed design include 1) potential for bias because the study is not blinded and 2) possible contamination of the comparison groups. In order to minimize these risks, efforts will be made to geographically separate the comparison groups to reduce the risk of sharing of water treatment products. Blinding is not possible given the obviously different nature of the three PoU water treatment approaches and the need for a control group.

02

Conditions studied

  • Marasmus
03

In context

Protein-Energy Malnutrition

40 studies on the registry are indexed under Protein-Energy Malnutrition; 7 are open to participants now.

This study's planned enrollment of 820 is above the median of 92 across 30 interventional studies indexed under Protein-Energy Malnutrition.

Browse Protein-Energy Malnutrition studies →

Lead sponsor

Action Contre la Faim is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 59 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children in each selected community will be eligible for inclusion in the study if they are

    1. between six and 59 months of age,
    2. diagnosed as an uncomplicated SAM case
    3. enrolled in ACF's CMAMprogram
    4. if the child's caretaker gives consent for the child's participation.

Exclusion criteria

Exclusion Criteria:

  • Children will be ineligible for participation if

    1. they have a diagnosis of kwashiorkor; OR 2) they require in-patient treatment for SAM
    2. their caretakers are unwilling or unable to agree to their participation.
  • Children graduating from in-patient treatment (i.e no remaining medical complications) to the out-patient CMAM program will be eligible for participation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
820 participants (estimated)

Study arms

  • Active comparator
    standard SAM treatment (control group)

    Standard Severe acute malnutrition treatment provided according to national nutrition protocol, in link with MoH health centers and structure.

    Other: Standard Severe Acute Malnutrition Treatment

  • Experimental
    SAM treatment + flocculent-disinfectant

    Standard Severe acute malnutrition treatment provided according to national nutrition protocol, in link with MoH health centers and structure. In addition, caregivers receive a flocculent-disinfectant for household level application.

    Other: Point of Use (PoU) water treatment flocculent disinfectant. · Other: Standard Severe Acute Malnutrition Treatment

  • Experimental
    SAM treatment + chlorine disinfectant

    Standard Severe acute malnutrition treatment provided according to national nutrition protocol, in link with MoH health centers and structure. In addition, caregivers receive a chlorine disinfectant for household level application.

    Other: Point of Use (PoU) water treatment chlorine disinfectant · Other: Standard Severe Acute Malnutrition Treatment

  • Experimental
    SAM treatment + ceramic water filter

    Standard Severe acute malnutrition treatment provided according to national nutrition protocol, in link with MoH health centers and structure. In addition, caregivers receive a ceramic water filter for household level application.

    Device: Point of Use (PoU) ceramic water filter · Other: Standard Severe Acute Malnutrition Treatment

Interventions

  • OtherPoint of Use (PoU) water treatment flocculent disinfectant.

    A household level point of use water treatment of a flocculent disinfectant will be tested.

  • OtherPoint of Use (PoU) water treatment chlorine disinfectant

    A household level point of use water treatment of a chlorine disinfectant will be tested.

  • DevicePoint of Use (PoU) ceramic water filter

    A household level point of use water treatment of a ceramic water filter will be tested.

  • OtherStandard Severe Acute Malnutrition Treatment

    Standard CMAM treatment.

06

What researchers measure

Primary outcomes

  1. Recovery rate

    the total number of cured children / total number of exited children (including cured, deceased, and lost to follow-up)

    Time frame: 5 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Doocy S, Tappis H, Villeminot N, Suk A, Kumar D, Fazal S, Grant A, Pietzsch S. Point-of-use water treatment improves recovery rates among children with severe acute malnutrition in Pakistan: results from a site-randomized trial. Public Health Nutr. 2018 Nov;21(16):3080-3090. doi: 10.1017/S1368980018001647. Epub 2018 Aug 22. PubMed 30132426 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2016 to primary completion in Oct 2016, 6 months.

Of 16 interventional studies with no phase under Protein-Energy Malnutrition, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 41. This study's 6 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 22, 2016
First posted
Apr 26, 2016
StartActual
Apr 2016
Primary completionActual
Oct 2016
CompletionEst.
Mar 2017
Last update
Jan 31, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 31, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02751476
Lead sponsor
Action Contre la Faim
Responsible party
Sponsor
First posted
Apr 26, 2016
Start date
Apr 2016
Primary completion
Oct 2016
Completion
Mar 2017 (estimated)
Last update
Jan 31, 2017

Study contacts

Shannon Doocy, PhD
principal investigator · Johns Hopkins University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion